Balanced news tone
News Sentiment
SPRB sentiment intelligence
Spruce Biosciences, Inc. Common Stock news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
54
Balanced news tone
49 relevant articles
Price is moving more forcefully than the current news tone suggests.
83/100 classification confidence.
directly relevant articles
high-authority source matches
-13.0% over one week, -16.8% over four weeks, trend inactive, and below fair value.
Certain Stock Options of Spruce Biosciences, Inc. are subject to a Lock-Up Agreement Ending on 20-JUL-2026.
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Primary event
Market update
83/100 classification
One-week reaction
-13.0%
Price reacting lower
Trend fit
Trend inactive
-16.8% over four weeks
Fair value
-42.2%
Below fair value
Value support
Sentiment Mix
Positive, neutral, negative
Positive
10
Neutral
37
Negative
2
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
marketscreener.com
Direct company coverage
Certain Stock Options of Spruce Biosciences, Inc. are subject to a Lock-Up Agreement Ending on 20-JUL-2026.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 Jul 2026 00:37
- Source
- marketscreener.com
ad-hoc-news.de
Direct company coverage
Molina Healthcare stock trades steadily as recent earnings and Medicaid membership growth underpin v
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 19 Jul 2026 16:48
- Source
- ad-hoc-news.de
Market source
Industry context
Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 16 Jul 2026 18:49
- Source
- Market source
Stocktwits
Direct company coverage
Why Did Vir Biotechnology Stock Surge 60% After-Hours Today?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 16 Jul 2026 18:18
- Source
- Stocktwits
Moomoo
Direct company coverage
B. Riley Securities Initiates Spruce Biosciences(SPRB.US) With Buy Rating, Announces Target Price $160
- Tone
- Positive 66/100
- Event
- Analyst action
- Published
- 13 Jul 2026 15:31
- Source
- Moomoo
Market source
Industry context
Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 13 Jul 2026 12:30
- Source
- Market source
MT Newswires
Direct company coverage
B. Riley Initiates Spruce Biosciences at Buy With $160 Price Target
- Tone
- Positive 58/100
- Event
- Analyst action
- Published
- 13 Jul 2026 12:28
- Source
- MT Newswires
DirectorsTalk Interviews
Direct company coverage
Teleflex Incorporated (TFX) Stock Analysis: Unpacking a 32.3% Revenue Growth in the Healthcare Sector
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 13 Jul 2026 09:24
- Source
- DirectorsTalk Interviews
Stock Titan
Direct company coverage
Spruce Biosciences (SPRB) CEO adds 266 shares through employee stock purchase plan
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jul 2026 20:15
- Source
- Stock Titan
Stock Titan
Direct company coverage
Spruce Biosciences CEO to speak at B. Riley healthcare summit
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jul 2026 20:04
- Source
- Stock Titan
Business Wire
Direct company coverage
Spruce Biosciences to Participate in the B. Riley Securities 2026 Mind, Muscle & Vision Healthcare Summit
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jul 2026 20:01
- Source
- Business Wire
timothysykes.com
Direct company coverage
Tenet Healthcare Stock Jumps As Analysts Hold Buy Ratings Into Earnings
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 04 Jul 2026 07:00
- Source
- timothysykes.com
Business Wire
Direct company coverage
Spruce Biosciences Joins the Russell 3000® Index
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Jun 2026 12:00
- Source
- Business Wire
TradingView
Direct company coverage
ETFs Investing in Spruce Biosciences, Inc. Stocks
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Jun 2026 05:29
- Source
- TradingView
Business Wire
Direct company coverage
Spruce Biosciences Appoints Agnieszka Jurecka, M.D., Ph.D., MPH, as Vice President, Medical Affairs
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Jun 2026 12:00
- Source
- Business Wire
Stock Titan
Direct company coverage
Spruce Biosciences taps rare-disease doctor for TA-ERT launch prep
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Jun 2026 07:00
- Source
- Stock Titan
Market source
Direct company coverage
Cooper Companies Stock: Is COO Underperforming the Healthcare Sector?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jun 2026 07:00
- Source
- Market source
Business Wire
Direct company coverage
Spruce Biosciences Appoints Eric Jordan as Vice President, Marketing and Tina Gullotta as Vice President, Finance and Corporate Controller
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jun 2026 12:00
- Source
- Business Wire
Market source
Direct company coverage
Puma Biotechnology Stock Rises 19% in 3 Months: Here's Why
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Jun 2026 07:00
- Source
- Market source
MT Newswires
Direct company coverage
Spruce Biosciences Reports Long-Term Data for Enzyme Replacement Therapy to Treat Genetic Disease MPS IIIB
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jun 2026 21:45
- Source
- MT Newswires
Business Wire
Direct company coverage
Spruce Biosciences Announces Long-Term Tralesinidase Alfa Enzyme Replacement Therapy Data in Sanfilippo Syndrome Type B (MPS IIIB) Presented at the 18th International MPS Symposium
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jun 2026 20:05
- Source
- Business Wire
eciks.org
Direct company coverage
UNH stock jumps on Q1 earnings beat and raised guidance to $18.25+
- Tone
- Positive 84/100
- Event
- Earnings
- Published
- 26 May 2026 07:00
- Source
- eciks.org
simplywall.st
Industry context
There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 15 May 2026 07:00
- Source
- simplywall.st
Market source
Industry context
Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 May 2026 07:00
- Source
- Market source
Investing News Network
Direct company coverage
Spruce Biosciences Reports First Quarter 2026 Financial Results and Provides Corporate Updates
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 13 May 2026 07:00
- Source
- Investing News Network
Quiver Quantitative
Direct company coverage
$SPRB ($SPRB) Releases Q1 2026 Earnings | SPRB Stock News
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 13 May 2026 07:00
- Source
- Quiver Quantitative
simplywall.st
Direct company coverage
Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- simplywall.st
Market source
Industry context
Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- Market source
Stock Titan
Direct company coverage
Spruce adds two rare-disease launch veterans before potential TA-ERT rollout
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 May 2026 07:00
- Source
- Stock Titan
Market source
Industry context
Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 25 Apr 2026 07:00
- Source
- Market source